USTR Urged To Pressure Canada On Revoked Drug Patents
The Canadian court's handling of drug patents has drawn the ire of Congress members, who have urged the U.S. Trade Representative to subject Canada to additional scrutiny and possible sanctions amid...To view the full article, register now.
Already a subscriber? Click here to view full article